Julie Borland
Research Triangle Park Foundation(US)GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Cardiac and Coronary Surgery Techniques, Pneumocystis jirovecii pneumonia detection and treatment, Nitric Oxide and Endothelin Effects
Most-Cited Works
- → Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers(2009)239 cited
- → Safety, Tolerability, and Pharmacokinetics of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily With Rifampin or Once Daily With Rifabutin(2012)191 cited
- → A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para‐aminohippurate clearance in healthy subjects(2012)186 cited
- → Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans(2013)136 cited
- → Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms(1995)121 cited
- → The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects(2016)120 cited